Nomura Asset Management CO LTD Kymera Therapeutics, Inc. Transaction History

Nomura Asset Management CO LTD

10 transactions

Quarter	Operation	Price Per share
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$20.91 - $34.27 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$20.91 - $34.27 $0 - $0
Q2 2022 Aug 12, 2022	BUY	$14.13 - $42.55 $0 - $0
Q1 2022 May 13, 2022	BUY	$35.3 - $64.68 $0 - $0
Q4 2021 Feb 01, 2022	BUY	$49.91 - $65.56 $0 - $0
Q3 2021 Nov 12, 2021	BUY	$47.8 - $66.66 $0 - $0
Q2 2021 Aug 06, 2021	BUY	$31.08 - $51.95 $0 - $0
Q1 2021 May 14, 2021	BUY	$35.64 - $85.46 $0 - $0
Q4 2020 Feb 12, 2021	BUY	$28.07 - $87.83 $0 - $0

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.28B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.